Association study of paroxetine therapeutic response with SERT gene polymorphisms in patients with major depressive disorder

References

• Bozina N, Medved V, Rojnic Kuzman M, Sain I, Sertic J. 2006a. Association study of olanzapine-induced weight gain and therapeutic response with SERT gene polymorphisms in female schizophrenic patients. J Psychopharmacol (Epub ahead of print, 8 November).
   PubMedGoogle Scholar
• Bozina N, Mihaljevic-Peles A, Sagud M, Jakovljevic M, Sertic J. Serotonin transporter polymorphism in Croatian patients with major depressive disorder. Psychiatr Danub 2006b; 18: 83–89
   PubMedGoogle Scholar
• Buchner A, Erdfelder E, Faul F 1997. How to Use G*Power [www document]. URL http://www.psycho.uni–duesseldorf.de/aap/projects/gpower/ how_to_use_gpower.html.
   Google Scholar
• Bradley SL, Dodelzon K, Sandhu HK, Philbert RA. Relationship of serotonin transporter gene polymorphisms and haplotypes to mRNA transcription. Am J Med Gen 2005; 136B: 58–61
   PubMedGoogle Scholar
• Collier DA, Stober G, Li T, et al. A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Mol Psychiatry 1996; 1: 453–460
   PubMed Web of Science ®Google Scholar
• Coyle N, Jones I, Robertson E, Lendon C, Craddock N. Variation at the serotonin transporter gene influences susceptibility to bipolar affective puerperal psychosis. Lancet 2000; 356: 1490–1491
   PubMed Web of Science ®Google Scholar
• Durham LK, Webb SM, Milos PM, Clary CM, Seymour AB. The serotonin transporter polymorphism, 5HTTLPR, is associated with a faster response time to sertraline in an elderly population with major depressive disorder. Psychopharmacology (Berlin) 2004; 174: 525–529
   PubMed Web of Science ®Google Scholar
• Fan JB, Sklar P. Meta-analysis reveals association between serotonin transporter gene STin2 VNTR polymorphism and schizophrenia. Mol Psychiatry 2005; 10: 928–938
   PubMed Web of Science ®Google Scholar
• First MB, Spitzer RL, Gibbon M, William JB. Structured clinical interview for DSM-IV axis disorders, clinician version (SCID-CV). American Psychiatric Association, Washington, DC 1996
   Google Scholar
• Hamilton M. A rating scale for depression. Neurol Neurosurg Psychiatry 1960; 23: 56–62
   PubMed Web of Science ®Google Scholar
• Hanna GL, Himle JA, Curtis GC, et al. Serotonin transporter and serotonin transporter promoter affects onset of paroxetine treatment seasonal variation in blood serotonin in families with obsessive–compulsive disorder. Neuropsychopharmacology 1998; 18: 102–111
   PubMed Web of Science ®Google Scholar
• Heils A, Teufel A, Petri S, et al. Allelic variation of human serotonin transporter gene expression. J Neurochem 1996; 66: 2621–2624
   PubMed Web of Science ®Google Scholar
• Hranilovic D, Stefulj J, Schwab S, et al. Serotonin transporter promoter and intron 2 polymorphisms: Relationship between allelic variants and gene expression. Biol Psychiatry 2004; 55: 1090–1094
   PubMed Web of Science ®Google Scholar
• Ito K, Yoshida K, Sato K, et al. A variable number of tandem repeats in the serotonin transporter gene does not affects the antidepressant response to fluvoxamine. Psychiatry Res 2002; 111: 235–239
   PubMed Web of Science ®Google Scholar
• Kato M, Ikenaga Y, Wakeno M, et al. Controlled clinical comparison of paroxetine and fluvoxamine considering the serotonin transporter promoter polymorphism. Int Clin Psychopharmacol 2005; 20: 151–156
   PubMed Web of Science ®Google Scholar
• Kim DK, Lim SW, Lee S, et al. Serotonin transporter gene polymorphism ant antidepressant response. Neuroreport 2001; 11: 215–219
   Google Scholar
• Kirchheiner J, Nickchen K, Bauer M, et al. Pharmacogenetic of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response. Mol Psychiatry 2004; 9: 442–473
   PubMed Web of Science ®Google Scholar
• Lesch KP, Bengel D, Heils A, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996; 274: 1527–1531
   PubMed Web of Science ®Google Scholar
• MacKenzie A, Quin J. A serotonin transporter gene intone 2 polymorphic regions, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo. Proc Natl Acad Sci USA 1999; 96: 15251–15255
   PubMed Web of Science ®Google Scholar
• Mundo E, Walker M, Cate T, Macciardi F, Kennedy JL. The role of serotonin transporter protein gene in antidepressant-induced mania in bipolar disorder: preliminary findings. Arch Gen Psychiatry 2001; 58: 539–544
   PubMed Web of Science ®Google Scholar
• Murphy GM, Jr, Hollander SB, Rodrigues HE, Kremer C, Schatzberg AF. Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression. Arch Gen Psychiatry 2004; 61: 1163–1169
   PubMed Web of Science ®Google Scholar
• Perlis RH, Mischoulon D, Smoller JW, et al. Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment. Biol Psychiatry 2003; 54: 879–883
   PubMed Web of Science ®Google Scholar
• Perna G, Favaron E, Di Bella D, Bussi R, Bellodi L. Efficacy of paroxetine and polymorphism within the promoter of the serotonin transporter gene. Neuropsychopharmacology 2005; 30: 2230–2235
   PubMed Web of Science ®Google Scholar
• Ramamoorthy S, Mauman AL, Moore KR, et al. Antidepressant and cocaine-sensitive human serotonin transporter:molecular cloning, expression, and chromosomal localization. Proc Natl Acad Sci USA 1993; 90: 2542–2546
   PubMed Web of Science ®Google Scholar
• Rauch JL, Johnson ME, Fei YJ, et al. Initial conditions of serotonin transporter kinetics and genotype: influence on SSRI trial outcome. Biol Psychiatry 2002; 51: 723–732
   PubMedGoogle Scholar
• Serretti A, Artioli P. From molecular biology to pharmacogenetics: a review of the literature on antidepressant treatment and suggestions of possible candidate genes. Psychopharmacology (Berlin) 2004; 174: 490–503
   PubMedGoogle Scholar
• Serretti A, Zanardi R, Cusin C, Rossini D, Lorenzi C, Smeraldi E. Tryptophan hydroxylase gene associated with paroxetine antidepressant activity. Eur Neuropsychopharmacol 2001; 11: 375–380
   PubMed Web of Science ®Google Scholar
• Serretti A, Kato M, De Ronchi D, Kinoshita T 2006 Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients. Mol Psychiatry 2006 [Epub ahead of print, 5 December].
   Google Scholar
• Smeraldi E, Zanardi R, Benedetti F, Di Bella D, Perez J, Catalano M. Polymorphism within the promoter of the serotonin transporter gene andantidepressant efficacy of fluvoxamine. Mol Psychiatry 1998; 3: 508–511
   PubMed Web of Science ®Google Scholar
• Smits KM, Smits LJM, Schouten JSAG, Stelma FF. Influence of SERTPR and Stin2 in the serotonin transporter gene on the effect of selective serotonin reuptake inhibitors in depression: a systematic review. Mol Psychiatry 2004; 9: 433–441
   PubMed Web of Science ®Google Scholar
• Smeraldi E, Benedetti F, Zanardi R. Serotonin transporter promoter genotype and illness recurrence in mood disorders. Eur Neuropsychopharmacol 2002; 12: 73–75
   PubMedGoogle Scholar
• Thase ME, Entsuah AR, Rudolph RL. Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. Br J Psychiatry 2001; 178: 234–241
   PubMed Web of Science ®Google Scholar
• Yoshida K, Ito K, Sato K, et al. Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients Progr Neuropsychopharmacol. Biol Psychiatry 2002; 26: 383–386
   Google Scholar
• Yoshida K, Takahashi H, Higuchi H, et al. Prediction of antidepressant response to milnacipran by norepinephrine transporter gene polymorphisms. Am J Psychiatry 2004; 161: 1575–1580
   PubMed Web of Science ®Google Scholar
• Yu YW-Y, Tsai SJ, Chen TJ, Lin CH, Hong CJ. Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders. Mol Psychiatry 2002; 7: 1115–1119
   PubMed Web of Science ®Google Scholar
• Zanardi R, Benedetti F, Di Bella D, Catalano M, Smeraldi E. Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of the serotonin transporter gene. J Clin Psychopharmacol 2002; 20: 105–107
   Google Scholar